Zoom Logo

COVID-19 Care Panel Hosted by LCMS - Shared screen with speaker view
D.McGrail, MD
30:50
Do you offer convalescent plasma to all your admitted COVID-19 patients?
Smitha Kurra
35:36
How long do you recommend anticoagulation for patients with PE at discharge.
Smitha Kurra
37:39
The abdominal abscess patient is mine and she is still testing positive almost 4 weeks later for covid and testing fifth time next week. She is at home hoping to get to an assisted living once negative
Donald Paynter
38:21
Are you routinely using anticoagulation in Covid-19 ICU patients? Are steroids helpful in the “cytokine storm?”
hp
39:29
In regards to diabetes being a risk factor for worse outcomes, are you seeing this mainly in poorly controlled diabetics, or are you seeing this with well controlled diabetics as well.
Smitha Kurra
49:27
How are Asthma patients doing? Any worse outcomes ? Information that I heard of Asthma may not be as much of a risk factor
craigclark1
55:23
Are ACE inhibitors of benefit? CEC
hp
56:58
Are you seeing a lot of Dermatologic signs as have been reported?
Smitha Kurra
59:55
COVID toes ? How often being seen. With microthrombi causing , will that need 6 months outpatient management of anticoagulation? Recommendations?
Fadi Yacoub
01:07:49
Craig?
Yacoub
01:12:07
How do you suppress the RNA polymerase?
dnelson
01:27:06
Since anticoagulation and antiplatelet therapy seem poorly effective once microvascular occlusion / endothelial dysfunction are clinically evident, are there any promising treatments that might be used in earlier stages to prevent this from happening?
Brian Privett
01:43:46
Do panelists think Iowa should have a universal masking initiative?
hp
01:47:06
Thank You
Smitha Kurra
01:47:16
Thank you very much
William Ching
01:47:16
Thank you!
Jerry
01:47:20
Thanks